Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia
Simone M.C. Spoorenberg(St. Antonius Ziekenhuis), Ewoudt van de Garde(St. Antonius Ziekenhuis), Ger T. Rijkers(Roosevelt University), Paul Voorn(St. Antonius Ziekenhuis), Rik Heijligenberg(Ziekenhuis Gelderse Vallei), Willem Jan W. Bos(St. Antonius Ziekenhuis), Jan C. Grutters(St. Antonius Ziekenhuis)
Cited by 24
Related Papers
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
|The Lancet|2011|372
Reconstruction of Brachial Artery Pressure From Noninvasive Finger Pressure Measurements
|Circulation|1996|363
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271
Comparative Survival among Older Adults with Advanced Kidney Disease Managed Conservatively Versus with Dialysis
|Clinical Journal of the American Society of Nephrology|2016|260
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis Patients
|American Journal of Kidney Diseases|2005|234